Medical Physics Direct Patient Care for the Improvement of Patient Understanding of Care

Barbara Ann Karmanos Cancer Institute

Status: Completed

Conditions: Malignant Neoplasm

Treatments: Other: Counseling; Other: Informational Intervention; Other: Questionnaire Administration

Study type: Interventional

Funder types: Other; NIH

Identifiers

NCT04266522

P30CA022453 (U.S. NIH Grant/Contract)

2019-104

Details and patient eligibility

About

This phase II trial studies how well medical physics direct patient care works in improving patients' understanding of their cancer treatment. Providing direct physicist-patient interactions and answering patients' questions about their cancer treatment may help patients to understand the care and therefore reduce anxiety and distress during treatment.

Full description

PRIMARY OBJECTIVE:

I. To evaluate whether the Medical Physics Direct Patient Care Initiative (MPDPCI) improves anxiety/distress.

SECONDARY OBJECTIVE:

II. To assess whether the MPDPCI improves patient treatment adherence and overall satisfaction.

OUTLINE: Patients are randomized to 1 of 2 arms.

ARM I: Patients receive printed materials describing the technical aspects of their treatment.

ARM II: Patients receive printed materials as in Arm I. Patients also receive a minimum of 2 direct physicist interactions to describe the technical aspects of their treatment either immediately prior to or immediately after treatment simulation.

Enrollment: 45 patients

Sex: All

Ages: 18+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Medical physicists will be eligible if they care for patients within the Gershenson Radiation Oncology Center within the Karmanos Cancer Institute and have completed the patient communication training
• Are able to read and write in English
• Are scheduled for curative radiation therapy at the Gershenson Radiation Oncology Center

Exclusion criteria

• NONE

Trial design

Primary purpose: Health Services Research

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

45 participants in 2 patient groups

Arm I (printed materials)

Active Comparator group

Description:

Patients receive printed materials describing the technical aspects of their treatment.

Treatment:

Other: Informational Intervention

Other: Questionnaire Administration

Arm II (printed materials, physicist interaction)

Experimental group

Description:

Patients receive printed materials as in Arm I. Patients also receive a minimum of 2 direct physicist interactions to describe the technical aspects of their treatment either immediately prior to or immediately after treatment simulation.

Treatment:

Other: Counseling

Other: Informational Intervention

Other: Questionnaire Administration